← Back to Search

Endoluminal Therapy

Endoscopic Therapy for Esophageal Achalasia

N/A

Waitlist Available

Led By Mohamed R Ali, MD

Research Sponsored by University of California, Davis

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Achalasia

Barrett's Esophagus

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3-6 months

Awards & highlights

Study Summary

This trial is testing different ways to treat digestive conditions using endoluminal therapies, which are procedures that go through the GI tract from the inside.

Who is the study for?

This trial is for adults aged 18-80 with various upper and lower GI conditions, including Achalasia, Barrett's Esophagus, GERD, and complications from bariatric surgery. Candidates must qualify for gastrointestinal surgeries of benign or malignant nature. Those unable to consent or not meeting the criteria for endoluminal treatments are excluded.Check my eligibility

What is being tested?

The study is evaluating the outcomes of different endoscopic interventions on patients with a range of GI disorders such as Esophageal Achalasia and complications post-bariatric surgery like fistulas and ulcers.See study design

What are the potential side effects?

While specific side effects are not listed here, endoscopic interventions may generally include risks such as sore throat, infection risk at the intervention site, bleeding, perforation of the GI tract, adverse reactions to sedatives used during procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with achalasia.

Select...

I have Barrett's Esophagus.

Select...

I have had bariatric surgery.

Select...

I am eligible for surgery to treat my gastrointestinal condition.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3-6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3-6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Decrease in GERDDQ

Secondary outcome measures

Decrease in Eckardt scoring

Trial Design

1Treatment groups

Experimental Treatment

Group I: TreatmentExperimental Treatment1 Intervention

Patients meeting inclusion criteria for possible surgical therapies for their current condition (IE Achelasia, Enlarged Gastric Pouch and/or Gastrogastric Fistula after primary weight loss surgery, etc) will be educated on the different therapy options including traditional laparoscopic surgery and/or Endoscopic Interventions including POEM (Percutaneous Oral Endoscopic Myomectomy for the treatment of Achelasia) or Endoscoscopic Pouch/GastroJejunostomy repair or closure of the Gastrogastric Fistula as examples.

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor

911 Previous Clinical Trials

4,709,083 Total Patients Enrolled

Mohamed R Ali, MDPrincipal InvestigatorU.C. Davis Medical Center

2 Previous Clinical Trials

660 Total Patients Enrolled

Media Library

Endoscopic Intervention (Endoluminal Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT03123835 — N/A

Endoscopic Intervention (Endoluminal Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03123835 — N/A

Achalasia Research Study Groups: Treatment

Achalasia Clinical Trial 2023: Endoscopic Intervention Highlights & Side Effects. Trial Name: NCT03123835 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria must individuals meet to be considered for enrollment in this clinical trial?

"Potential participants for this trial must meet two criteria: they should have marginal ulcers and be aged between 18-80 years old. There is a total capacity of 500 applicants."

Answered by AI

Are enlistments still occurring for this clinical experiment?

"Clinicaltrials.gov confirms that this particular study is not, at present, recruiting patients; the trial was posted on March 1st 2016 and last updated July 7th 2022. However, there are 421 other trials actively seeking candidates for participation now."

Answered by AI